Triamcinolone–moxifloxacin combo prevents macular edema in diabetic retinopathy after cataract surgery
Researchers have found in a new study that Triamcinolone acetonide–moxifloxacin maintained the stability of postoperative central macular thickness (CMT) in patients undergoing cataract surgery with preexisting diabetic retinopathy in the short term. The research has been published recently in the Journal of Cataract & Refractive Surgery.
Clinically significant macular oedema (CSMO) present at the time of cataract surgery is likely to progress and eyes with previously treated CSMO are at increased risk of recurrence. The risk of progression is increased if the operation is complicated by excessive manipulation, vitreous loss, or severe post-operative inflammation.
Researchers evaluated the effect of intravitreal triamcinolone acetonide–moxifloxacin at the time of cataract surgery on central macular edema in patients with preexisting diabetic retinopathy.
The retrospective chart review included 75 eyes of 64 patients who had undergone recent cataract surgery. Intravitreal injection of triamcinolone–moxifloxacin was given at the time of surgery.
"We aimed to record the visual acuity and central macular thickness (CMT) with optical coherence tomography at preoperative and postoperative visits," says Julia Angkadjaja, MD, Loma Linda University Eye Institute, Loma Linda University Health, Loma Linda, California, USA.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.